Clinical Trial

HEmorrhoidAl Disease in Inflammatory Bowel Disease: a Multicenter Prospective Cohort Study

Study acronym: HEAD-IBD-II
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Patients who will undergo surgery for HD after the diagnosis of IBD over a 12-month period will be enrolled across Europe. Primary objective of this study is to determine the safety and effectiveness of surgical treatments for HD in a large multicenter cohort of IBD patients. Secondary aim is to identify factors that may affect clinical and surgical outcomes.
Trial Details
NCT Number NCT06638814
Lead Sponsor Treviso Regional Hospital
Conditions IBD (Inflammatory Bowel Disease), Hemorrhoid, Safety, Sugery, Surgery Related Complications Rate
Enrollment 50 participants
Start Date 2025-01-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-01-31 (estimated)
Updated on ClinicalTrials.gov 2024-10-15